Cargando…
M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis
Necroptosis has emerged as a novel and crucial player in acute and chronic liver diseases. Necroptotic cells lead to the release of DAMPs including S100A9, followed by the development of necroinflammation. We previously have documented the beneficial hepatoprotection conferred by M2-like macrophages...
Autores principales: | Bai, Li, Kong, Ming, Duan, Zhongping, Liu, Shuang, Zheng, Sujun, Chen, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814003/ https://www.ncbi.nlm.nih.gov/pubmed/33462187 http://dx.doi.org/10.1038/s41419-020-03378-w |
Ejemplares similares
-
Galectin-3 critically mediates the hepatoprotection conferred by M2-like macrophages in ACLF by inhibiting pyroptosis but not necroptosis signalling
por: Bai, Li, et al.
Publicado: (2022) -
Neonatal obstructive nephropathy induces necroptosis and necroinflammation
por: Popper, Bastian, et al.
Publicado: (2019) -
Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B
por: Ren, Yan, et al.
Publicado: (2022) -
Cellular Mechanisms of Hepatoprotection Mediated by M2-Like Macrophages
por: Bai, Li, et al.
Publicado: (2018) -
Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B
por: Wu, Rui, et al.
Publicado: (2018)